Literature DB >> 24452504

Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates.

Matthew J Maenner1, Catherine E Rice2, Carrie L Arneson3, Christopher Cunniff4, Laura A Schieve2, Laura A Carpenter5, Kim Van Naarden Braun2, Russell S Kirby6, Amanda V Bakian7, Maureen S Durkin3.   

Abstract

IMPORTANCE: The DSM-5 contains revised diagnostic criteria for autism spectrum disorder (ASD) from the DSM-IV-TR. Potential impacts of the new criteria on ASD prevalence are unclear.
OBJECTIVE: To assess potential effects of the DSM-5 ASD criteria on ASD prevalence estimation by retrospectively applying the new criteria to population-based surveillance data collected for previous ASD prevalence estimation. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional, population-based ASD surveillance based on clinician review of coded behaviors documented in children's medical and educational evaluations from 14 geographically defined areas in the United States participating in the Autism and Developmental Disabilities Monitoring (ADDM) Network in 2006 and 2008. This study included 8-year-old children living in ADDM Network study areas in 2006 or 2008, including 644 883 children under surveillance, of whom 6577 met surveillance ASD case status based on the DSM-IV-TR. MAIN OUTCOMES AND MEASURES: Proportion of children meeting ADDM Network ASD criteria based on the DSM-IV-TR who also met DSM-5 criteria; overall prevalence of ASD using DSM-5 criteria.
RESULTS: Among the 6577 children classified by the ADDM Network as having ASD based on the DSM-IV-TR, 5339 (81.2%) met DSM-5 ASD criteria. This percentage was similar for boys and girls but higher for those with than without intellectual disability (86.6% and 72.5%, respectively; P < .001). A total of 304 children met DSM-5 ASD criteria but not current ADDM Network ASD case status. Based on these findings, ASD prevalence per 1000 for 2008 would have been 10.0 (95% CI, 9.6-10.3) using DSM-5 criteria compared with the reported prevalence based on DSM-IV-TR criteria of 11.3 (95% CI, 11.0-11.7). CONCLUSIONS AND RELEVANCE: Autism spectrum disorder prevalence estimates will likely be lower under DSM-5 than under DSM-IV-TR diagnostic criteria, although this effect could be tempered by future adaptation of diagnostic practices and documentation of behaviors to fit the new criteria.

Entities:  

Mesh:

Year:  2014        PMID: 24452504      PMCID: PMC4041577          DOI: 10.1001/jamapsychiatry.2013.3893

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  29 in total

1.  National autism prevalence trends from United States special education data.

Authors:  Craig J Newschaffer; Matthew D Falb; James G Gurney
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

2.  Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study.

Authors:  Marja-Leena Mattila; Marko Kielinen; Sirkka-Liisa Linna; Katja Jussila; Hanna Ebeling; Risto Bloigu; Robert M Joseph; Irma Moilanen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-06       Impact factor: 8.829

3.  Sensitivity and specificity of proposed DSM-5 diagnostic criteria for autism spectrum disorder.

Authors:  James C McPartland; Brian Reichow; Fred R Volkmar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-03-14       Impact factor: 8.829

4.  Exploring the proposed DSM-5 criteria in a clinical sample.

Authors:  Azin Taheri; Adrienne Perry
Journal:  J Autism Dev Disord       Date:  2012-09

5.  Three Reasons Not to Believe in an Autism Epidemic.

Authors:  Morton Ann Gernsbacher; Michelle Dawson; H Hill Goldsmith
Journal:  Curr Dir Psychol Sci       Date:  2005-04

6.  Brief report: comparability of DSM-IV and DSM-5 ASD research samples.

Authors:  C A Mazefsky; J C McPartland; H Z Gastgeb; N J Minshew
Journal:  J Autism Dev Disord       Date:  2013-05

7.  The changing prevalence of autism in California.

Authors:  Lisa A Croen; Judith K Grether; Jenny Hoogstrate; Steve Selvin
Journal:  J Autism Dev Disord       Date:  2002-06

8.  Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.

Authors: 
Journal:  MMWR Surveill Summ       Date:  2007-02-09

9.  Prevalence and incidence of autism spectrum disorder in an Israeli population.

Authors:  Michael Davidovitch; Beatriz Hemo; Patricia Manning-Courtney; Eric Fombonne
Journal:  J Autism Dev Disord       Date:  2013-04

10.  Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an adult autism spectrum disorder diagnostic clinic.

Authors:  C Ellie Wilson; Nicola Gillan; Deborah Spain; Dene Robertson; Gedeon Roberts; Clodagh M Murphy; Stefanos Maltezos; Janneke Zinkstok; Katie Johnston; Christina Dardani; Chris Ohlsen; P Quinton Deeley; Michael Craig; Maria A Mendez; Francesca Happé; Declan G M Murphy
Journal:  J Autism Dev Disord       Date:  2013-11
View more
  56 in total

1.  Autism Spectrum Disorder: Incidence and Time Trends Over Two Decades in a Population-Based Birth Cohort.

Authors:  Scott M Myers; Robert G Voigt; Robert C Colligan; Amy L Weaver; Curtis B Storlie; Ruth E Stoeckel; John D Port; Slavica K Katusic
Journal:  J Autism Dev Disord       Date:  2019-04

2.  Comparison of DSM-IV-TR and DSM-5 Criteria in Diagnosing Autism Spectrum Disorders in Singapore.

Authors:  Min Sung; Tze Jui Goh; Bei Lin Joelene Tan; Jialei Stephanie Chan; Hwee Sen Alvin Liew
Journal:  J Autism Dev Disord       Date:  2018-10

3.  Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years.

Authors:  Hao Zhou; Xiu Xu; Weili Yan; Xiaobing Zou; Lijie Wu; Xuerong Luo; Tingyu Li; Yi Huang; Hongyan Guan; Xiang Chen; Meng Mao; Kun Xia; Lan Zhang; Erzhen Li; Xiaoling Ge; Lili Zhang; Chunpei Li; Xudong Zhang; Yuanfeng Zhou; Ding Ding; Andy Shih; Eric Fombonne; Yi Zheng; Jisheng Han; Zhongsheng Sun; Yong-Hui Jiang; Yi Wang
Journal:  Neurosci Bull       Date:  2020-06-30       Impact factor: 5.203

Review 4.  Epidemiological surveys of ASD: advances and remaining challenges.

Authors:  Eric Fombonne; Heather MacFarlane; Alexandra C Salem
Journal:  J Autism Dev Disord       Date:  2021-04-17

5.  Autism in the broader context of cognitive sex differences.

Authors:  David C Geary
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

6.  The social responsiveness scale in relation to DSM IV and DSM5 ASD in Korean children.

Authors:  Keun-Ah Cheon; Jee-In Park; Yun-Joo Koh; Jungeun Song; Hyun-Joo Hong; Young-Kee Kim; Eun-Chung Lim; Hojang Kwon; Mina Ha; Myung-Ho Lim; Ki-Chung Paik; John N Constantino; Bennett Leventhal; Young Shin Kim
Journal:  Autism Res       Date:  2016-09-08       Impact factor: 5.216

7.  A Prospective Study of the Concordance of DSM-IV and DSM-5 Diagnostic Criteria for Autism Spectrum Disorder.

Authors:  Micah O Mazurek; Frances Lu; Heather Symecko; Eric Butter; Nicole M Bing; Rachel J Hundley; Marie Poulsen; Stephen M Kanne; Eric A Macklin; Benjamin L Handen
Journal:  J Autism Dev Disord       Date:  2017-09

8.  Exposure to General Anesthesia May Contribute to the Association between Cesarean Delivery and Autism Spectrum Disorder.

Authors:  Maayan Huberman Samuel; Gal Meiri; Ilan Dinstein; Hagit Flusser; Analiya Michaelovski; Asher Bashiri; Idan Menashe
Journal:  J Autism Dev Disord       Date:  2019-08

9.  Accuracy of Reported Community Diagnosis of Autism Spectrum Disorder.

Authors:  Moran Hausman-Kedem; Barry E Kosofsky; Gail Ross; Kaleb Yohay; Emily Forrest; Margaret H Dennin; Reena Patel; Kristen Bennett; James P Holahan; Mary J Ward
Journal:  J Psychopathol Behav Assess       Date:  2018-01-20

10.  Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network.

Authors:  Deborah A Bilder; Amanda V Bakian; David A Stevenson; Paul S Carbone; Christopher Cunniff; Alyson B Goodman; William M McMahon; Nicole P Fisher; David Viskochil
Journal:  J Autism Dev Disord       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.